Nakamura Y, Kitano S, Takahashi A, Tsutsumida A, Namikawa K, Tanese K, Abe T, Funakoshi T, Yamamoto N, Amagai M, Yamazaki N. Nivolumab for advanced melanoma: pretreatment prognostic factors and early outcome markers during therapy. Oncotarget.　2016; 7: 77404-77415.

Yamagami J, Nakamura Y( Co-first author), Nagao K, Funakoshi T, Takahashi H, Tanikawa A, Hachiya T, Yamamoto T, Ishida-Yamamoto A, Tanaka T, Fujimoto N, Nishigori C, Yoshida T, Ishii N, Hashimoto T, Amagai M Vancomycin Mediates IgA Autoreactivity in Drug-Induced Linear IgA Bullous Dermatosis. J Invest Dermatol. 2018; 138:1473-1480.

Nakamura Y, Tanese K, Hirai I, Kameyama K, Kawakami Y, Amagai M, Funakoshi T. Evaluation of appropriate surgical margin for pigmented basal cell carcinoma according to the risk factor for recurrence: A single-institute retrospective study in Japan. J Eur Acad Dermatol Venereol. 2018; 32: e453-e455.

Nakamura Y, Tanese K, Hirai I, Amagai M, Kawakami Y, Funakoshi T. Serum cytokeratin 19 fragment 21-1 and carcinoembryonic antigen combination assay as a biomarker of tumour progression and treatment response in extramammary Paget’s disease. Br J Dermatol. 2019 Feb 21. 181, 535-543.

Nakamura Y, Mizukami H, Tanese K, Fusumae T, Hirai I, Amagai M, Takamatsu R, Nakamura K, Nishihara H, Takimoto T, Ueno M, Saya H, Funakoshi T. Role of androgen signaling in androgen receptor-positive extramammary Paget's disease: Establishment of organoids and their biological analysis as a novel therapeutic target. J Dermatol Sci
. 2023;112:23-30.